NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.
about
Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCCNovel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinomaComprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsOutlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients.Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung CancerSalivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances.A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility.Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.Altered histone mark deposition and DNA methylation at homeobox genes in human oral squamous cell carcinomaSignaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinomaPDGFRβ Is a Novel Marker of Stromal Activation in Oral Squamous Cell CarcinomasCpG island methylation profile in non-invasive oral rinse samples is predictive of oral and pharyngeal carcinoma.The epigenetic landscape of oral squamous cell carcinomaEpigenetic mechanisms in oral carcinogenesis.Salivary biomarker development using genomic, proteomic and metabolomic approaches.New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer.EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.DNA methylation as clinically useful biomarkers-light at the end of the tunnelUnique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinomaMetastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy.The bidirectional association between oral cancer and esophageal cancer: A population-based study in Taiwan over a 28-year period.Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Novel Epigenetic Biomarkers Mediating Bisphenol A Exposure and Metabolic Phenotypes in Female Mice.MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patientsDiagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers testedLooking in the mouth for noninvasive gene expression-based methods to detect oral, oropharyngeal, and systemic cancer.More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers.MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis.Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.Serum, plasma and saliva biomarkers for head and neck cancer.Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinomaSilencing of uPAR via RNA interference inhibits invasion and migration of oral tongue squamous cell carcinomaTRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma
P2860
Q21561014-8AFD617F-5072-4962-9FAF-C3ACE12BCE5EQ28383468-8945B8EA-DA33-4797-A56A-A9DDB3F321BFQ28485279-3ED5F7EC-FFEE-470B-8E70-5A1F9BCD24DDQ30278379-793F72B2-018E-4030-B83C-F674921EB6B3Q31036731-E17E2C0A-47ED-4E09-885D-D1D45B27F136Q33683154-494EC29C-509F-46ED-B40B-4B2B7C43F574Q33827693-31CDA21B-A79E-4002-8A9A-EC2DE61F1C0EQ34084254-B126E20E-C149-4704-A411-0F5E6B98DF66Q34388943-CF2C3F76-3121-4B25-8227-BC49DC772BB1Q34902060-80684A11-4E98-406E-BB8C-11F6B56027C3Q35179223-18D810F5-D439-4B21-85E1-EEC001EB5648Q35688540-D276C537-D100-491E-A99F-C01ABAA11C42Q36003190-2FC1BE0C-DB9A-4591-87C9-834FEE35729CQ36344111-C16E0C26-DA13-4A1E-A4D8-B929A49F343AQ36594150-7CA9259F-ED3B-4D5A-9F3B-A867332CBF4DQ36602726-49E14E1D-4F9A-4416-9C89-352FE2368C9EQ36632967-12A1A4A3-5A84-4DC9-97B3-726B9D1F2D7BQ36648996-92CC1553-AF7D-4661-9AD6-D9B48929B33AQ36807422-D2A35343-7046-41CE-9827-E3A8CEB17760Q36941462-08EF0E6F-7D97-4FC5-8203-5E9632F4FAA1Q37148677-EE40E793-CC9D-4D6F-94B5-12B8F8CB6FBDQ37481100-FBFA2DCB-4613-4456-A339-5B5E730D338BQ37694718-D544B750-746F-4B42-868E-502270495DFAQ38081950-946D7560-CF68-49C9-BB55-2DB6CE555DC7Q38676670-DDE4D8BD-1523-4649-BE59-819EA26DA8D1Q38738057-364C9FD1-3157-4312-B7CB-8DDDCD2CB762Q39186868-A55296C5-ADF8-4765-9033-7AC12A9A5BD8Q39205095-BDB1E10D-7C99-4CF5-BE44-085F11F3ACEFQ41612255-37035A60-5900-4672-A650-9B4F021A1AA2Q41911994-A14ADF55-6A0E-43AF-A3B3-A7263FCA05BCQ42534413-D2B6E0E6-BF74-4AC1-A488-0169EE529B2DQ44201624-B19F7C58-7BAA-4624-BD67-356EB6263D52Q47138374-3E1AB439-2C72-485A-AA65-ADDA283BB1E6Q47154066-F8A0E292-C30E-47B9-B023-31879C2A87BAQ47253661-93D7B24D-320A-47D6-AEA0-6366515098A5Q47405806-99F3AAEA-03F5-456B-A8B5-823F15EFFDA4Q57152715-D1D8A016-DA2A-42BB-A065-AB3B16045E75Q57165696-17F90CF9-B29F-418E-944C-3BC131DB6498Q58799384-C6D77E8A-3A7F-4034-A788-20D8D46D5C86
P2860
NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
NID2 and HOXA9 promoter hyperm ...... carcinoma tissues and saliva.
@ast
NID2 and HOXA9 promoter hyperm ...... carcinoma tissues and saliva.
@en
type
label
NID2 and HOXA9 promoter hyperm ...... carcinoma tissues and saliva.
@ast
NID2 and HOXA9 promoter hyperm ...... carcinoma tissues and saliva.
@en
prefLabel
NID2 and HOXA9 promoter hyperm ...... carcinoma tissues and saliva.
@ast
NID2 and HOXA9 promoter hyperm ...... carcinoma tissues and saliva.
@en
P2093
P2860
P50
P1476
NID2 and HOXA9 promoter hyperm ...... l carcinoma tissues and saliva
@en
P2093
C Engstrom
C Ili-Gangas
D Sidransky
G Macía-Colón
J Califano
M Berdasco
P2860
P304
P356
10.1158/1940-6207.CAPR-11-0006
P577
2011-05-10T00:00:00Z